These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 62795)

  • 1. The L1210 leukemia cell bears a B lymphocyte specific, non-H-2 linked alloantigen.
    Freund JG; Ahmed A; Budd RE; Dorf ME; Sell KW; Vannier WE; Humphreys RE
    J Immunol; 1976 Nov; 117(5 Pt.2):1903-5. PubMed ID: 62795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the mixed lymphocyte culture response with anti-Lyb-4.1 serum 1,2,
    Freund JG; Ahmed A; Dorf ME; Sell KW; Humphreys RE
    J Immunol; 1977 Apr; 118(4):1143-9. PubMed ID: 66278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
    Ishikawa H; Kubota E; Suzuki H; Saito K
    J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on non-H-2-linked lymphocyte-activating determinants. II. Nonexpression of Mls determinants in a mouse strain with an X-linked B lymphocyte immune defect.
    Ahmed A; Scher I
    J Immunol; 1976 Nov; 117(5 Pt.2):1922-6. PubMed ID: 62796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo treatment with monoclonal anti-I-A antibodies: disappearance of splenic antigen-presenting cell function concomitant with modulation of splenic cell surface I-A and I-E antigens.
    Kruisbeek AM; Titus JA; Stephany DA; Gause BL; Longo DL
    J Immunol; 1985 Jun; 134(6):3605-14. PubMed ID: 2580891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210.
    Rahman SM; Kawashima K; Nakashima I; Nagase F
    Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new lymphocyte cell surface antigen, Ly-22.2, controlled by a locus on chromosome 4 and a second unlinked locus.
    Meruelo D; Offer M; Flieger N
    J Immunol; 1983 Feb; 130(2):946-50. PubMed ID: 6184409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ly 9, an alloantigenic marker of lymphocyte differentiation.
    Mathieson BJ; Sharrow SO; Bottomly K; Fowlkes BJ
    J Immunol; 1980 Nov; 125(5):2127-36. PubMed ID: 7000897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of the immune response to the H-2Dk private specificity, H-2.32. II. Genetic linkage analysis of a backcross generation.
    Shinohara N; Hansen TH; Schurko E; McKenzie IF; Sachs DH
    J Immunol; 1978 Dec; 121(6):2472-6. PubMed ID: 82586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucyl-leucine methyl ester treatment of donor cells permits establishment of immunocompetent parent----F1 chimeras that are selectively tolerant of host alloantigens.
    Thiele DL; Calomeni JA; Lipsky PE
    J Immunol; 1987 Oct; 139(7):2137-42. PubMed ID: 3309052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte response to minor H-42a alloantigen in H-42b mice: clonal inactivation of the precursor cytotoxic T lymphocytes by veto-like spleen cells that express the H-42a antigen.
    Ishikawa H; Hino T; Kato H; Suzuki H; Saito K
    J Immunol; 1986 Oct; 137(7):2080-8. PubMed ID: 3489752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation requirements of cloned inducer T cells. III. Need for two stimulator cells in the response of a cloned line to Mls determinants.
    DeKruyff RH; Ju ST; Laning J; Cantor H; Dorf ME
    J Immunol; 1986 Aug; 137(4):1109-14. PubMed ID: 2426352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ly-4.2: a cell membrane alloantigen of murine B lymphocytes. I. Population studies.
    McKenzie IF; Snell GD
    J Immunol; 1975 Feb; 114(2 pt 2):848-55. PubMed ID: 1078681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BP-3 alloantigen. A cell surface glycoprotein that marks early B lineage cells and mature myeloid lineage cells in mice.
    McNagny KM; Cazenave PA; Cooper MD
    J Immunol; 1988 Oct; 141(8):2551-6. PubMed ID: 3262662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
    Wettstein PJ; Colombo MP
    J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tumor immunogenicity of DBA/2 mouse lymphoma L1210 and its sublines. III. Control of host resistance to drug-resistant L1210 sublines by H-2-linked and non-H-2-linked genes.
    Fuji H; Murakami M
    J Natl Cancer Inst; 1983 Jan; 70(1):119-25. PubMed ID: 6296515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.